Jennifer G. Goldman, MD, MS

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

1. Clinical features of neurodegeneration with brain iron accumulation due to a C19orf12 gene mutation.
   Goldman JG, Eichenseer SR, Berry-Kravis E, Zimnowodzki S, Gregory A, Hogarth P, Hayflick SJ.
   Mov Disord. 2013
   2013 Mar 13. doi: 10.1002/mds.25410. [Epub ahead of print] No abstract available.
   
2. New NBIA subtype: Genetic, clinical, pathologic, and radiographic features of MPAN.
   Hogarth P, Gregory A, Kruer MC, Sanford L, Wagoner W, Natowicz MR, Egel RT, Subramony SH, Goldman JG, Berry-Kravis E, Foulds NC, Hammans SR, Desguerre I, Rodriguez D, Wilson C, Diedrich A, Green S, Tran H, Reese L, Woltjer RL, Hayflick SJ.
   Neurology. 2013
   2013 Jan 15
   80(3):268-275. Epub 2012 Dec 26.
   
3. Two in one: report of a patient with spinocerebellar ataxia types 2 and 10.
   Kapur SS, Goldman JG.
   Arch Neurol. 2012
   2012 Sep 1
   69(9):1200-3. doi: 10.1001/archneurol.2011.3044.
   
4. Spinocerebellar ataxia types 2 and 10: more than a coincidental association?-Reply.
   Kapur SS, Goldman JG.
   Arch Neurol. 2012
   2012 Nov
   69(11):1524-5. doi: 10.1001/archneurol.2012.2771. No abstract available.
   
5. Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia.
   Goldman JG, Stebbins GT, Bernard B, Stoub TR, Goetz CG, deToledo-Morrell L.
   Mov Disord. 2012
   2012 May
   27(6):727-34. doi: 10.1002/mds.24938. Epub 2012 Mar 12.
   
6. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.
   Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M.
   Mov Disord. 2012
   2012 Mar
   27(3):349-56. doi: 10.1002/mds.24893. Epub 2012 Jan 24. Review.
   
7. Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.
   Goldman JG, Weis H, Stebbins G, Bernard B, Goetz CG.
   Mov Disord. 2012
   2012 Aug
   27(9):1129-36. doi: 10.1002/mds.25062. Epub 2012 Jul 6.
   
8. An update expert opinion on management and research strategies in Parkinson's disease psychosis.
   Goldman JG, Vaughan CL, Goetz CG.
   Expert Opin Pharmacother.
   2011 Sep
   12(13):2009-24
   
9. Combined measures of movement and force variability distinguish Parkinson's disease from essential tremor.
   Poon C, Robichaud JA, Corcos DM, Goldman JG, Vaillancourt DE.
   Clin Neurophysiol.
   2011 Nov
   122(11):2268-75
   
10. New thoughts on thought disorders in Parkinson's disease: review of current research strategies and challenges
    Goldman JG
    Parkinsons Dis
    2011 Mar 2
    2011:675630
    
11. MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI.
    Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Tröster AI, Weintraub D.
    Mov Disord.
    2011 Jun 9
    doi: 10.1002/mds.23823
    
12. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
    Barton B, Grabli D, Bernard B, Czernecki V, Goldman JG, Stebbins G, Dubois B, Goetz CG.
    Mov Disord.
    2011 Dec 9
    doi: 10.1002/mds.24059
    
13. Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations.
    Goldman JG, Marr D, Zhou L, Ouyang B, Leurgans SE, Berry-Kravis E, Goetz CG.
    Mov Disord.
    2011 Aug 1
    26(9):1781-2. doi: 10.1002/mds.23655
    
14. A recommended scale for cognitive screening in clinical trials of Parkinson's disease
    Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Growdon J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Tröster AI, Uc EY; Parkinson Study Group Cognitive/Psychiatric Working Group
    Mov Disord
    2010 Nov 15
    25(15):2501-7
    
15. Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies
    Goldman JG, Goetz CG, Brandabur M, Sanfilippo M, Stebbins GT
    Mov Disord
    2008 Nov 15
    23(15):2248-50